143 related articles for article (PubMed ID: 37952733)
1. Liuweiwuling Tablet relieves the inflammatory transformation of hepatocellular carcinoma by inhibiting the PI3K/AKT/NF-κB signaling pathway.
Chen Y; Song Z; Hou X; Liu J; Zheng C; Zhao X; Lv G; Li J; Xiu Y; Shi W; Zhao J; Yang H; Wang Y; Zhao J; Zhan X; Niu M; Zou W; Bai Z; Xiao X
J Ethnopharmacol; 2024 Mar; 321():117406. PubMed ID: 37952733
[TBL] [Abstract][Full Text] [Related]
2. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hepatitis B virus
Ge FL; Yang Y; Si LL; Li YH; Cao MZ; Wang J; Bai ZF; Ren ZG; Xiao XH; Liu Y
World J Gastroenterol; 2024 Apr; 30(13):1911-1925. PubMed ID: 38659485
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of Liuweiwuling tablets on carbon tetrachloride-induced hepatic fibrosis in rats.
Liu H; Zhang Z; Hu H; Zhang C; Niu M; Li R; Wang J; Bai Z; Xiao X
BMC Complement Altern Med; 2018 Jul; 18(1):212. PubMed ID: 29986685
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of Panlongqi Tablets intervening in vertebral artery type of cervical spondylosis in rats through PI3K/AKT signaling pathway based on network pharmacology and experimental verification].
Ming RR; Zhang YQ; Xu Y; Xu TT; Fang LC; Wang JX; Wang XX; Hu ZX; Yang C; Jia KX; Wang L; Liu CF; Lin N
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(16):4454-4461. PubMed ID: 36046875
[TBL] [Abstract][Full Text] [Related]
6. Modified Biejia Jianwan decoction restrains PD-L1-mediated immune evasion through the HIF-1α/STAT3/NF-κB signaling pathway.
Tian X; Liu F; Wang Z; Zhang J; Liu Q; Zhang Y; Zhang D; Huang C; Zhao J; Jiang S
J Ethnopharmacol; 2024 Mar; 322():117577. PubMed ID: 38104877
[TBL] [Abstract][Full Text] [Related]
7. An Integrative Pharmacology Based Analysis of Refined Liuweiwuling Against Liver Injury: A Novel Component Combination and Hepaprotective Mechanism.
Gao Y; Shi W; Yao H; Ai Y; Li R; Wang Z; Liu T; Dai W; Xiao X; Zhao J; Niu M; Bai Z
Front Pharmacol; 2021; 12():747010. PubMed ID: 34630116
[TBL] [Abstract][Full Text] [Related]
8. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.
Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z
BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122
[TBL] [Abstract][Full Text] [Related]
9. Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways.
El-Hanboshy SM; Helmy MW; Abd-Alhaseeb MM
Mol Biol Rep; 2021 Nov; 48(11):7233-7242. PubMed ID: 34596810
[TBL] [Abstract][Full Text] [Related]
10. Baiheqingjin formula reduces inflammation in mice with asthma by inhibiting the PI3K/AKT/NF-κb signaling pathway.
Yan X; Tong X; Jia Y; Zhao Y; Zhang Q; Hu M; Li X; Li B; Ming X; Xie Y; Wu X; Yu X; Qu L; Xiong L; Huang F; Nie J
J Ethnopharmacol; 2024 Mar; 321():117565. PubMed ID: 38081397
[TBL] [Abstract][Full Text] [Related]
11. Sini San ameliorates CCl4-induced liver fibrosis in mice by inhibiting AKT-mediated hepatocyte apoptosis.
Jiang M; Huang C; Wu Q; Su Y; Wang X; Xuan Z; Wang Y; Xu F; Ge C
J Ethnopharmacol; 2023 Mar; 303():115965. PubMed ID: 36460296
[TBL] [Abstract][Full Text] [Related]
12. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways.
Zhang B; Lai L; Tan Y; Liang Q; Bai F; Mai W; Huang Q; Ye Y
J Ethnopharmacol; 2020 May; 254():112714. PubMed ID: 32105750
[TBL] [Abstract][Full Text] [Related]
13. Involvement of NF-κB/PI3K/AKT signaling pathway in the protective effect of prunetin against a diethylnitrosamine induced hepatocellular carcinogenesis in rats.
Li G; Qi L; Chen H; Tian G
J Biochem Mol Toxicol; 2022 May; 36(5):e23016. PubMed ID: 35239232
[TBL] [Abstract][Full Text] [Related]
14. Targeting the PI3K/pAKT/mTOR/NF-κB/FOXO3a signaling pathway for suppressing the development of hepatocellular carcinoma in rats: Role of the natural remedic Suaeda vermiculata forssk.
Abdel-Bakky MS; Mohammed HA; Mahmoud NI; Amin E; Alsharidah M; Al Rugaie O; Ewees MG
Environ Toxicol; 2024 Jun; 39(6):3666-3678. PubMed ID: 38506534
[TBL] [Abstract][Full Text] [Related]
15. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
16. Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF-κB signalling pathways.
Lin X; Li Y; Zhang X; Wei Y; Wen S; Lu Z; Huang Q; Wei J
Cell Biochem Funct; 2021 Jan; 39(1):77-87. PubMed ID: 32564421
[TBL] [Abstract][Full Text] [Related]
17. Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway.
Fu C; Zhang Y; Xi WJ; Xu K; Meng F; Ma T; Li W; Wu L; Chen Z
J Ethnopharmacol; 2023 May; 308():116191. PubMed ID: 36731809
[TBL] [Abstract][Full Text] [Related]
18. Exploring the molecular mechanism of Artemisia rupestris L. for the treatment of hepatocellular carcinoma via PI3K/AKT pathway.
Zhang S; Cai X; Khan GJ; Cheng J; He J; Zhai K; Mao Y
J Ethnopharmacol; 2024 Mar; 322():117572. PubMed ID: 38097024
[TBL] [Abstract][Full Text] [Related]
19. Semen Brassicae ameliorates hepatic fibrosis by regulating transforming growth factor-β1/Smad, nuclear factor-κB, and AKT signaling pathways in rats.
Cao S; Zheng B; Chen T; Chang X; Yin B; Huang Z; Shuai P; Han L
Drug Des Devel Ther; 2018; 12():1205-1213. PubMed ID: 29785090
[TBL] [Abstract][Full Text] [Related]
20. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
